Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease

Cancer Research

Volumn 61, Issue 16, 2001, Pages 6029-6033

  Xiao, Zhen ^a   Adam, Bao Ling ^a   Cazares, Lisa H ^a   Clements, Mary A ^a   Davis, John W ^a   Schellhammer, Paul F ^a   Wright, George L ^a   Dalmasso, Enrique A ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b CIPHERGEN BIOSYSTEMS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DNA MICROARRAY; HUMAN; IMMUNOASSAY; LASER; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARBOXYPEPTIDASES; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; IMMUNOASSAY; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0035881634     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Monoclonal antibodies to a new antigenic marker in epithelial prostate cells and serum of prostatic cancer patients
2. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids
3. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues
4. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: Study of 184 cases
5. Prostate-specific membrane antigen expression in normal and malignant human tissues
6. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization
7. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy
8. Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastasis
9. A dual-monoclonal sandwich assay for prostate-specific membrane antigen: Levels in tissues, seminal fluid and urine
10. Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients
11. Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement
12. Measurement of prostate-specific membrane antigen in the serum with a new antibody
13. Comparison of prostate specific membrane antigen and prostate specific antigen levels in prostatic cancer patients
14. Prostate specific membrane antigen (PSMA) levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer
15. Generation of a baculovirus recombinant prostate-specific membrane antigen and its use in the development of a novel protein biochip quantitative immunoassay
16. Proteinchip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: A novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures
17. 111Indium-labeled CYT-356 for the detection of occult prostate cancer recurrence
18. Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)
19. Prostate specific antigen: A decade of discovery - What we have learned where we are going
20. Prostate-specific antigen and other prostate cancer markers
21. The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: Relationship to gland volume and age
22. Cost-effective prostate cancer detection. Reduction of low-yield biopsies